Prostatis Group’s Innovator Equity Defined Protection ETF - 1 Yr November ZNOV Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNOV
NA
HI
ABWM
TWP
SC
AWM
Prostatis Group's ZNOV Position: Q1 2026 in Review
Prostatis Group increased its Innovator Equity Defined Protection ETF - 1 Yr November (ZNOV) stake by 113% in Q1 2026, buying an estimated $676K and bringing the position to 47,538 shares worth $1.26M. The position accounts for 0.32% of the portfolio, ranked #69.
Prostatis Group first reported a position in ZNOV in Q4 2025 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold ZNOV as of Q1 2026.
- Prostatis Group held 47,538 shares of Innovator Equity Defined Protection ETF - 1 Yr November worth $1.26M as of Q1 2026.
- Prostatis Group bought 25,271 Innovator Equity Defined Protection ETF - 1 Yr November shares in Q1 2026, an estimated $676K.
- Innovator Equity Defined Protection ETF - 1 Yr November made up 0.32% of Prostatis Group's portfolio in Q1 2026, its #69 holding.
- Prostatis Group first reported a position in Innovator Equity Defined Protection ETF - 1 Yr November in Q4 2025 and has held it in 2 quarters since.
- 76 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr November as of Q1 2026.
Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.